Bone and Parathyroid Scintigraphy Findings in Sagliker Syndrome.

IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Molecular Imaging and Radionuclide Therapy Pub Date : 2024-02-22 DOI:10.4274/mirt.galenos.2023.24382

Çağlagül Erol, Özlem Şahin, Ahmet Eren Şen, Zeynep Aydın

引用次数: 0

Abstract

Sagliker syndrome (SS) is a rare, exaggerated form of chronic kidney disease (CKD)-mineral and bone disorder resulting from untreated secondary hyperparathyroidism due to CKD. Herein, we describe a 34-year-old male patient whose Tc-99m-methylene diphosphonate bone scintigraphy and Tc-99m-sestamibi parathyroid scintigraphy revealed hints of SS and exhibited its defining characteristics.

查看原文本刊更多论文

萨格里克综合征的骨骼和甲状旁腺闪烁扫描结果

萨格利克综合征（Sagliker syndrome，SS）是慢性肾脏病（CKD）的一种罕见、夸张的矿物质和骨骼疾病，由于CKD引起的继发性甲状旁腺功能亢进症未经治疗而导致。在这里，我们描述了一名34岁的男性患者，他的Tc-99m-亚甲基二膦酸盐骨闪烁扫描和Tc-99m-sestamibi甲状旁腺闪烁扫描显示出了SS的蛛丝马迹，并表现出了SS的特征。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Molecular Imaging and Radionuclide Therapy RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-

CiteScore

1.30

自引率

0.00%

发文量

期刊介绍： Molecular Imaging and Radionuclide Therapy (Mol Imaging Radionucl Ther, MIRT) is publishes original research articles, invited reviews, editorials, short communications, letters, consensus statements, guidelines and case reports with a literature review on the topic, in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry and radiobiology.